-
Ab179373-100μg
Anrukinzumab (anti-IL-13) (C007B-328898)
Price: $190.21List Price: $211.35Anrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Ab179373-10mg
Anrukinzumab (anti-IL-13) (C007B-328899)
Price: $2,431.05List Price: $2,701.17Anrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Ab179373-1mg
Anrukinzumab (anti-IL-13) (C007B-328900)
Price: $632.31List Price: $702.57Anrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Ab179373-5mg
Anrukinzumab (anti-IL-13) (C007B-328901)
Price: $1,580.96List Price: $1,756.62Anrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
A01978-40
Anti-Tocilizumab Antibody (14B10), mAb, Mouse,40ug
Price: $353.16List Price: $392.40Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S. -
A01980-40
Anti-Tocilizumab Antibody (6C10)(Biotin), mAb, Mouse,40ug
Price: $353.16List Price: $392.40Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S. -
A01979-40
Anti-Tocilizumab Antibody (6C10), mAb, Mouse,40ug
Price: $353.16List Price: $392.40Tocilizumab also known as atlizumab, is a humanized monoclonal antibody that is approved by the U.S. -
A01932-40
Anti-Tocilizumab Antibody, pAb, Rabbit,40ug
Price: $503.49List Price: $559.43Tocilizumab (Actemra) is a humanized monoclonal antibody that is developed by Hoffmann–La Roche and Chugai for the trea&tradeent of patients with rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in -
25155-1-AP
Atg2 Autophagy Related 2 Homolog B (S. Cerevisiae)
Price: $927.23List Price: $1,030.25The ATG2B antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ATG2B. This antibody recognizes human antigen. The ATG2B antibody has been validated for the following applications: ELISA, WB, IHC, IF analysis. -
Ab183417-100μg
Atinumab (anti-NOGO) (C007B-552915)
Price: $190.21List Price: $211.35Atinumab (anti-NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI). -
Ab183417-10mg
Atinumab (anti-NOGO) (C007B-552916)
Price: $2,395.99List Price: $2,662.21Atinumab (anti-NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI). -
Ab183417-1mg
Atinumab (anti-NOGO) (C007B-552917)
Price: $620.15List Price: $689.05Atinumab (anti-NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI).